Severity measurement scales for atopic dermatitis are important in clinical trials as objective outcome measures and they are often required for government and private insurance plans. These scales are sometimes underused by clinicians for a number of reasons, including time constraints and lack familiarity. Dr Patrick Fleming joins Dr Kirk Barber, editor-in-chief of the Journal of Cutaneous Medicine and Surgery, to talk about his article in the July/August edition of the Journal, reviewing the most commonly used atopic dermatitis measurement scales and gives his take on user guides and scoring explanations and inter-scale comparisons.Dr Patrick Fleming is an assistant professor of dermatology at the University of Toronto, and a dermatologist at Lynde Dermatology in Markham, Ont. And he is also working at the COVID Centre at Women's College Hospital.JCMS Author Interviews is produced by David McGuffin of Explore Productions.Our theme music is by Lee Rosevere.